Modern Diagnostic & Research Centre Ltd544673Corporate

Latest results: Mar 2026 1 quarters of data

—

MCap —

Live price not available

Modern Diagnostic & Research Centre Ltd — Stock analysis & AI research Modern Diagnostic & Research Centre Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹40 Cr

Sales · Mar 2026

₹5 Cr

Operating Profit · Mar 2026

12.7%

OPM % · Mar 2026

₹2 Cr

Net Profit · Mar 2026

₹1.38

EPS · Mar 2026

📝 Modern Diagnostic & Research Centre Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

Modern Diagnostic & Research Centre Ltd reported revenue of ₹40 crore for the quarter ended March 2026 (Q4 FY26).

Net profit stood at ₹2 crore. Earnings per share (EPS) came in at ₹1.38.

Operating profit stood at ₹5 crore — an operating margin (OPM) of 12.7%.

Shareholding pattern

As of Mar 2026, promoters held 72.85%, foreign institutional investors (FIIs) 0.03%, domestic institutional investors (DIIs) 15.49%, public shareholders 11.63% of Modern Diagnostic & Research Centre Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

12.2%

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹40 Cr

PAT — latest qtr ?

₹2 Cr

YoY qtr sales growth ?

N/A

YoY qtr profit growth ?

N/A

Sales growth (3y) ?

14%

Sales growth (5y) ?

N/A

Profit growth (3y) ?

43%

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹37 Cr

Debt to Equity ?

0.63

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

72.85%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (1 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2026	YoY %	QoQ %
Sales	40	—	—
Operating Profit	5	—	—
Other Income	0	—	—
Interest	1	—	—
Depreciation	3	—	—
Profit Before Tax	1	—	—
Net Profit	2	—	—
EPS	1.38	—	—
OPM %	12.7%	—	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	1.00	1.00	11.00	15.10	+37.3%
Reserves	4.96	10.76	9.73	43.45	+346.6%
Borrowings	15.31	20.46	22.09	37.10	+67.9%
Other Liabilities	15.27	17.26	21.76	22.95	+5.5%
Total Liabilities	36.54	49.48	64.58	118.60	+83.6%
Fixed Assets	23.67	27.04	30.65	48.10	+56.9%
CWIP	0.00	3.60	8.95	10.18	+13.7%
Investments	0.11	0.21	0.23	16.97	+7278.3%
Other Assets	12.76	18.63	24.75	43.35	+75.2%
Total Assets	36.54	49.48	64.58	118.60	+83.6%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	-0.12	7.93	13.73	3.82	-72.2%
Cash from Investing Activity	2.11	-11.03	-13.14	-40.29	-206.6%
Cash from Financing Activity	-6.47	3.36	-0.22	45.08	+20590.9%
Net Cash Flow	-4.48	0.26	0.37	8.62	+2229.7%
Free Cash Flow	-3.27	-3.04	0.58	-19.88	-3527.6%
CFO/OP	12%	60%	98%	36%	-63.3%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	52.27	56.28	59.75	69.30	+16.0%
Inventory Days	40.62	61.45	95.47	119.58	+25.3%
Days Payable	170.83	177.12	160.28	196.43	+22.6%
Cash Conversion Cycle	-77.94	-59.39	-5.06	-7.55	-49.2%
Working Capital Days	-58.82	-34.74	-41.53	-43.87	-5.6%
ROCE %	-17.24%	32.75%	38.99%	12.18%	-68.8%

👥 Shareholding (latest 1 periods)

Metric	Mar 2026	% Chg
Promoters	72.85%	—
FIIs	0.03%	—
DIIs	15.49%	—
Public	11.63%	—
No. of Shareholders	282	—

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was Modern Diagnostic & Research Centre Ltd's revenue in Q4 FY26?